Vital Images Inc. announced the global release of VitreaExtend, an advanced visualization solution that supports up to three simultaneous users with high performance similar to Vital's advanced server-based solution.
The ability to generate patient specific mammographic dose using volumetric breast density data from 2-D mammography and 3-D tomosynthesis was among the research presented at the 12th International Workshop on Breast Imaging (IWDM 2014), June 29-July 2, 2014.
Elekta has selected Birst, the global leader in cloud-based business intelligence (BI), to help clinicians, researchers and business managers exploit the potential of big data in their decision-making.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Delegates from academia and industry flocked to see the world's first commercial, cryogen free, 7.0T, preclinical magnetic resonance imaging (MRI) imaging, which went on display for the first time at the recent joint ISMRM/ESMRMB meeting in Milan, Italy and the SNMMI meeting in St Louis.
The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last week.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
There were several new cardiovascular ultrasound technology advances highlighted at the American Society of Echocardiography (ASE) annual meeting June 20-24 in Portland, Ore. Among these was the first commercial software released to analyze vector flow imaging, a possible new way to help with early diagnoses of some types of cardiovascular disease prior to symptoms developing. Another technology of note was high-resolution 3-D reconstructions of vascular plaques and any associated angiogenesis vasa vasorum, which could be a new way to noninvasively identify vulnerable plaque.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
More than 55 companies displayed their latest products and services at the American Society of Echocardiography (ASE) 25th Annual Scientific Sessions June 20-24 in Portland, Ore. The meeting is the largest for cardiovascular ultrasound. Highlights from the show floor included:
April 8 has come and gone. Microsoft XP support is over. Our use of XP-based picture archive and communications system (PACS) should be as well. But it’s not.
Along with the growing amount of data being collected in electronic medical records (EMR) and other information repositories is the growing need to dissect and analyze that data fast and efficiently. With hospitals and practices looking to maximize efficiencies and optimize quality within their operations, having a set of analytics tools can be a key strategy for moving forward with an evolving healthcare environment.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
This year marked the first of Stage 2 Meaningful Use (MU) for eligible providers, eligible hospitals and critical access hospitals (CAH) that already completed the required years of attestation to Stage 1 — three years if beginning Stage 1 in 2011, two years for those who began after. The objectives for Stage 2 are similar to Stage 1: all providers must meet a set of “core” objectives while also reporting on a number of available “menu” objectives, in order to attain MU certification and receive payments under the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs. For Stage 2 MU, eligible professionals must meet 17 core objectives and three menu objectives; eligible hospitals and CAHs will need to meet 16 core objectives and three menu objectives.
In today’s healthcare environment, longstanding, volume-based models of healthcare delivery are giving way to models where payers are tightening their purse strings and putting a greater emphasis on treatment value. Medical imaging providers are increasingly looking for a strategy to streamline workflows, enhance referral networks, increase referrals and better manage imaging appropriateness. Advanced interoperability is that strategy.
DAIC Editor Dave Fornell highlights his choices for some of the most innovative new technology at the American Society ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Although the fundamental workflow has not changed for treatment planning systems over the years, as technology improves, new features are added to enhance workflow and function.
Imaging displays, from consumer to medical grade, have come a long way since the days of bulky screens and low resolutions. Today, flat panel displays in the healthcare arena have increasing capacity to offer improved contrast ratios, truer colors, better energy efficiency, high luminance and more. A variety of vendors continue to improve the technology to better display imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, positron emission tomography (PET), mammography and ultrasound, and to ensure screens remain DICOM (digital imaging and communications in medicine) compliant.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Tomotherapy and volumetric modulated arc therapy (VMAT) have emerged as two popular types of intensity modulated radiation therapy (IMRT) for the treatment of complex tumors. Because physicians can modulate or control the intensity of the radiation beam in VMAT and tomotherapy, both treatments provide high precision radiation with which tumors that are curved around critical organs can be treated.
Cardiac ultrasound technology has advanced to keep up with several trends. These include improved workflow for greater efficiency, expanded use of qualification metrics, expanded use of 3-D echo to speed exam times and improve operator reproducibility, and expanded use of 3-D transesophageal echo (TEE) to aid guidance in the growing area of transcatheter structural heart procedures. Here are a few examples of how the newest technology is addressing these trends.
With the addition of its third 3D mammography system in early 2014, the University of Colorado Hospital established 3D as the standard of care in its breast imaging department. Located in Aurora, Colo., the hospital currently provides mammograms in two centers in the Denver area, and on its “Pink Lifesaver” mammography coach, which covers surrounding communities. The transition to 3D got a jump-start from fundraising efforts by the hospital’s “Men for the Cure” foundation, with donations from the group used to purchase the first 3D system and the mobile coach.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular imaging technologies, clinical applications, and translational and advanced research topics for molecular imaging professionals — nuclear medicine physicians, scientists, radiologists, cardiologists, pharmacists, technologists, researchers, and others involved and interested in nuclear medicine and molecular imaging and therapy.
Fujifilm Medical Systems U.S.A. Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) of the Aspire Cristalle.
Siemens Healthcare recently submitted its premarket approval application (PMA) for the Mammomat Inspiration with Breast Tomosynthesis option to the U.S. Food and Drug Administration (FDA)